VIATRIS INC (VTRS) Stock Fundamental Analysis
NASDAQ:VTRS - Nasdaq - US92556V1061 - Common Stock - Currency: USD
VTRS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. VTRS has a medium profitability rating, but doesn't score so well on its financial health evaluation. VTRS is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year VTRS was profitable.
VTRS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VTRS reported negative net income in multiple years.
In the past 5 years VTRS always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -9.85%, VTRS is in the better half of the industry, outperforming 68.39% of the companies in the same industry.
Looking at the Return On Equity, with a value of -24.22%, VTRS is in the better half of the industry, outperforming 67.88% of the companies in the same industry.
VTRS's Return On Invested Capital of 3.68% is amongst the best of the industry. VTRS outperforms 81.35% of its industry peers.
VTRS had an Average Return On Invested Capital over the past 3 years of 4.05%. This is significantly below the industry average of 14.98%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.85% | ||
| ROE | -24.22% | ||
| ROIC | 3.68% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
1.3 Margins
The Operating Margin of VTRS (10.63%) is better than 82.38% of its industry peers.
VTRS's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 40.69%, VTRS is doing good in the industry, outperforming 61.14% of the companies in the same industry.
In the last couple of years the Gross Margin of VTRS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.63% | ||
| PM (TTM) | N/A | ||
| GM | 40.69% |
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
2. Health
2.1 Basic Checks
VTRS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for VTRS has been reduced compared to 1 year ago.
Compared to 5 years ago, VTRS has more shares outstanding
Compared to 1 year ago, VTRS has an improved debt to assets ratio.
2.2 Solvency
VTRS has an Altman-Z score of 0.92. This is a bad value and indicates that VTRS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.92, VTRS perfoms like the industry average, outperforming 57.51% of the companies in the same industry.
VTRS has a debt to FCF ratio of 7.66. This is a slightly negative value and a sign of low solvency as VTRS would need 7.66 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 7.66, VTRS belongs to the best of the industry, outperforming 81.35% of the companies in the same industry.
VTRS has a Debt/Equity ratio of 0.91. This is a neutral value indicating VTRS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.91, VTRS is doing worse than 70.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 7.66 | ||
| Altman-Z | 0.92 |
ROIC/WACC0.46
WACC7.99%
2.3 Liquidity
VTRS has a Current Ratio of 1.68. This is a normal value and indicates that VTRS is financially healthy and should not expect problems in meeting its short term obligations.
VTRS has a Current ratio of 1.68. This is in the lower half of the industry: VTRS underperforms 66.32% of its industry peers.
VTRS has a Quick Ratio of 1.68. This is a bad value and indicates that VTRS is not financially healthy enough and could expect problems in meeting its short term obligations.
VTRS has a Quick ratio of 0.97. This is in the lower half of the industry: VTRS underperforms 76.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.68 | ||
| Quick Ratio | 0.97 |
3. Growth
3.1 Past
VTRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.37%.
Measured over the past years, VTRS shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.73% on average per year.
Looking at the last year, VTRS shows a decrease in Revenue. The Revenue has decreased by -6.71% in the last year.
The Revenue has been growing slightly by 5.09% on average over the past years.
EPS 1Y (TTM)-12.37%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-25.37%
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%-11.17%
3.2 Future
The Earnings Per Share is expected to grow by 2.92% on average over the next years.
VTRS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.21% yearly.
EPS Next Y-14.8%
EPS Next 2Y-3.05%
EPS Next 3Y1.6%
EPS Next 5Y2.92%
Revenue Next Year-6.93%
Revenue Next 2Y-2.64%
Revenue Next 3Y-1.33%
Revenue Next 5Y-0.21%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 3.84, which indicates a rather cheap valuation of VTRS.
Based on the Price/Earnings ratio, VTRS is valued cheaper than 96.89% of the companies in the same industry.
VTRS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.54.
A Price/Forward Earnings ratio of 3.82 indicates a rather cheap valuation of VTRS.
Based on the Price/Forward Earnings ratio, VTRS is valued cheaper than 96.89% of the companies in the same industry.
VTRS is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.28, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.84 | ||
| Fwd PE | 3.82 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VTRS is valued cheaply inside the industry as 95.85% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, VTRS is valued cheaper than 95.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.04 | ||
| EV/EBITDA | 5.52 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.05%
EPS Next 3Y1.6%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.49%, VTRS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.15, VTRS pays a better dividend. On top of this VTRS pays more dividend than 97.41% of the companies listed in the same industry.
VTRS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.49% |
5.2 History
VTRS has been paying a dividend for at least 10 years, so it has a reliable track record.
VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
The earnings of VTRS are negative and hence is the payout ratio. VTRS will probably not be able to sustain this dividend level.
DP-15.18%
EPS Next 2Y-3.05%
EPS Next 3Y1.6%
NASDAQ:VTRS (8/8/2025, 1:16:09 PM)
9.525
+0.13 (+1.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners85.07%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner Change26.32%
Market Cap11.18B
Analysts54.67
Price Target10.9 (14.44%)
Short Float %3.26%
Short Ratio3.06
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.49% |
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-15.18%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.57%
Min EPS beat(2)-7.28%
Max EPS beat(2)0.14%
EPS beat(4)2
Avg EPS beat(4)0.33%
Min EPS beat(4)-7.28%
Max EPS beat(4)8.74%
EPS beat(8)4
Avg EPS beat(8)0.13%
EPS beat(12)7
Avg EPS beat(12)0.7%
EPS beat(16)10
Avg EPS beat(16)2.09%
Revenue beat(2)0
Avg Revenue beat(2)-2.85%
Min Revenue beat(2)-4.31%
Max Revenue beat(2)-1.38%
Revenue beat(4)0
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)-0.84%
Revenue beat(8)0
Avg Revenue beat(8)-2.22%
Revenue beat(12)0
Avg Revenue beat(12)-2.76%
Revenue beat(16)2
Avg Revenue beat(16)-2.15%
PT rev (1m)0%
PT rev (3m)-3.28%
EPS NQ rev (1m)0.36%
EPS NQ rev (3m)0.19%
EPS NY rev (1m)0%
EPS NY rev (3m)0.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.84 | ||
| Fwd PE | 3.82 | ||
| P/S | 0.78 | ||
| P/FCF | 6.04 | ||
| P/OCF | 5.03 | ||
| P/B | 0.71 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.52 |
EPS(TTM)2.48
EY26.04%
EPS(NY)2.49
Fwd EY26.15%
FCF(TTM)1.58
FCFY16.56%
OCF(TTM)1.89
OCFY19.89%
SpS12.21
BVpS13.33
TBVpS-6.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.85% | ||
| ROE | -24.22% | ||
| ROCE | 4.65% | ||
| ROIC | 3.68% | ||
| ROICexc | 3.77% | ||
| ROICexgc | 13.71% | ||
| OM | 10.63% | ||
| PM (TTM) | N/A | ||
| GM | 40.69% | ||
| FCFM | 12.92% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
ROICexc(3y)4.16%
ROICexc(5y)3.64%
ROICexgc(3y)17.86%
ROICexgc(5y)17.54%
ROCE(3y)5.12%
ROCE(5y)4.54%
ROICexcg growth 3Y-9.04%
ROICexcg growth 5Y-13.17%
ROICexc growth 3Y4.9%
ROICexc growth 5Y-4.57%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
F-Score5
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 7.66 | ||
| Debt/EBITDA | 3.23 | ||
| Cap/Depr | 12.99% | ||
| Cap/Sales | 2.6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 50.65% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.68 | ||
| Quick Ratio | 0.97 | ||
| Altman-Z | 0.92 |
F-Score5
WACC7.99%
ROIC/WACC0.46
Cap/Depr(3y)14.64%
Cap/Depr(5y)17.2%
Cap/Sales(3y)2.72%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.37%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-25.37%
EPS Next Y-14.8%
EPS Next 2Y-3.05%
EPS Next 3Y1.6%
EPS Next 5Y2.92%
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%-11.17%
Revenue Next Year-6.93%
Revenue Next 2Y-2.64%
Revenue Next 3Y-1.33%
Revenue Next 5Y-0.21%
EBIT growth 1Y2.71%
EBIT growth 3Y-4.1%
EBIT growth 5Y1.89%
EBIT Next Year-6.55%
EBIT Next 3Y0.86%
EBIT Next 5Y1%
FCF growth 1Y-20.6%
FCF growth 3Y-7.94%
FCF growth 5Y6.95%
OCF growth 1Y-20.16%
OCF growth 3Y-8.61%
OCF growth 5Y5.01%